Provide $5 million in dedicated federal funding for alpha-gal syndrome research through the FY2027 National Defense Authorization Act.

Emanuel Cleaver · Missouri · Democratic

spending impact 0.72 specificity 0.95 extraction confidence 90%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

has submitted an amendment to the National Defense Authorization Act for Fiscal Year 2027 (NDAA) to provide $5 million in federal funding for alpha-gal syndrome research

Cleaver announced an amendment to the FY2027 NDAA intended to provide $5 million for alpha-gal syndrome research and said he was leading the effort to secure dedicated federal funding.

Congressman Cleaver Submits Amendment to Provide $5 Million for Alpha-gal Syndrome Research | Congressman Emanuel Cleaver
primary · press_release · model gpt-5.5

Evidence

legacy_unverified · Source version not recorded · locator unknown

The House Armed Services Committee floor amendment tracker lists floor amendment 104 / Rules amendment 0867 by Cleaver (MO), with Van Drew (NJ), stating it increases Combat and Operational Medicine Program R&D research by $5 million for alpha-gal syndrome research, offset by a $5 million reduction to advanced development; outcome: EB 1 Agreed to by Voice Vote.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Cleaver's specific $5 million alpha-gal research amendment was taken up in the House NDAA floor process and agreed to by voice vote, showing concrete House-side adoption but not final enactment.

partial same_term A for effort

FY27 NDAA Floor Amendment Tracker
secondary · model gpt-5.5 · confidence 93%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

The House Clerk records Roll Call Number 278 on July 22, 2026 for H.R. 8800, National Defense Authorization Act for Fiscal Year 2027; vote question: On Passage; status: Passed; yeas 216, nays 212, not voting 3.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The House passed the FY2027 NDAA after Cleaver's amendment had been agreed to, advancing the funding authorization through the House. This remains partial because the evidence does not show final NDAA enactment or appropriated funds obligated.

partial same_term A for effort

House Clerk Roll Call 278 on H.R. 8800, National Defense Authorization Act for Fiscal Year 2027
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): partial. same_term A for effort

Cleaver materially advanced the promised $5 million alpha-gal syndrome research funding by offering the relevant FY2027 NDAA amendment, which was agreed to by voice vote and included before House passage of H.R. 8800 on July 22, 2026. However, the evidence shows only House-side adoption and passage, not final NDAA enactment or funds being appropriated or obligated, so the promised funding has not yet been fully delivered.

provider codex_cli · model gpt-5.5 · confidence 90%